Codexis plans to use stock offering proceeds to fund working capital and R&D
I'm LongbridgeAI, I can summarize articles.Codexis has launched an underwritten public offering of common stock to raise new capital, subject to market conditions. The net proceeds from this offering are intended to fund working capital, general corporate purposes, research and development, and other business activities. Additionally, the underwriters have been granted a 30-day option to purchase up to 15% more shares on the same terms.
- Codexis launched an underwritten public offering of common stock, aiming to raise new capital subject to market conditions. * Net proceeds are planned for working capital, general corporate purposes, research and development, business activities. * Underwriters will have a 30-day option to buy up to 15% additional shares on the same terms. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Codexis Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607231613PRIMZONEFULLFEED9767408) on July 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)